{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:38:05Z","timestamp":1784734685836,"version":"3.55.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"am","delay-in-days":278,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006751","name":"US Department of the Army","doi-asserted-by":"publisher","award":["W81XWH-18-2-0044"],"award-info":[{"award-number":["W81XWH-18-2-0044"]}],"id":[{"id":"10.13039\/100006751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004883","name":"Illinois Department of Agriculture","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004883","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006438","name":"Office of the Assistant Secretary for Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006438","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.neuropharm.2025.110675","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:27:56Z","timestamp":1756945676000},"page":"110675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Testing the effect of the non-selective opioid PPL-138 in a model of alcohol relapse in the context of PTSD"],"prefix":"10.1016","volume":"280","author":[{"given":"Sophia","family":"Draughon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Idriss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2371-7135","authenticated-orcid":false,"given":"Kylie","family":"Kealoha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meira","family":"Gildin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lauber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Carper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4501-7573","authenticated-orcid":false,"given":"Lawrence","family":"Toll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3246-8703","authenticated-orcid":false,"given":"Kelly M.","family":"Standifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8151-0579","authenticated-orcid":false,"given":"Andrea","family":"Cippitelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2025.110675_bib1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.bbr.2009.11.030","article-title":"Yohimbine stress potentiates conditioned cue-induced reinstatement of heroin-seeking in rats","volume":"208","author":"Banna","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110675_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13009","article-title":"Stress-induced escalation of alcohol self-administration, anxiety-like behavior, and elevated amygdala Avp expression in a susceptible subpopulation of rats","volume":"26","author":"Barchiesi","year":"2021","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2025.110675_bib3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.biopsych.2022.12.003","article-title":"Oxytocin reduces sensitized stress-induced alcohol relapse in a model of posttraumatic stress disorder and alcohol use disorder comorbidity","volume":"94","author":"Becker","year":"2023","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110675_bib4","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1037\/0893-164X.10.2.124","article-title":"Posttraumatic stress disorder and substance abuse relapse among women: a pilot study","volume":"10","author":"Brown","year":"1996","journal-title":"Psychol. Addict. Behav."},{"key":"10.1016\/j.neuropharm.2025.110675_bib5","first-page":"1414","article-title":"Long-lasting resistance to extinction of response reinstatement induced by ethanol-related stimuli: role of genetic ethanol preference","volume":"25","author":"Ciccocioppo","year":"2001","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2025.110675_bib6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.biopsych.2006.01.006","article-title":"Buprenorphine reduces alcohol drinking through activation of the nociceptin\/orphanin FQ-NOP receptor system","volume":"61","author":"Ciccocioppo","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110675_bib7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.neuropharm.2015.02.005","article-title":"Pharmacological stress is required for the anti-alcohol effect of the alpha3beta4\u2217 nAChR partial agonist AT-1001","volume":"93","author":"Cippitelli","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110675_bib8","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00213-018-4883-y","article-title":"Differential regulation of alcohol taking and seeking by antagonism at alpha4beta2 and alpha3beta4 nAChRs","volume":"235","author":"Cippitelli","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2025.110675_bib9","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.pbb.2011.10.016","article-title":"Pharmacological blockade of corticotropin-releasing hormone receptor 1 (CRH1R) reduces voluntary consumption of high alcohol concentrations in non-dependent Wistar rats","volume":"100","author":"Cippitelli","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2025.110675_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109045","article-title":"PPL-138 (BU10038): a bifunctional NOP\/mu partial agonist that reduces cocaine self-administration in rats","volume":"211","author":"Cippitelli","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110675_bib11","article-title":"The opioid partial agonist PPL-138 reduces alcohol self-administration in rats susceptible to post-traumatic stress disorder","author":"Cippitelli","year":"2025","journal-title":"Br. J. Pharmacol. 2025 Aug 9. Online ahead of print. PMID: 40782008"},{"key":"10.1016\/j.neuropharm.2025.110675_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.721999","article-title":"TNF-alpha as an initiator of allodynia and anxiety-like behaviors in a preclinical model of PTSD and comorbid pain","volume":"12","author":"Dib","year":"2021","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110675_bib13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/acer.13267","article-title":"Psychiatric, demographic, and brain morphological predictors of relapse after treatment for an alcohol use disorder","volume":"41","author":"Durazzo","year":"2017","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2025.110675_bib14","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.bbr.2013.09.014","article-title":"Single prolonged stress impairs social and object novelty recognition in rats","volume":"256","author":"Eagle","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110675_bib15","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neures.2012.11.001","article-title":"Single prolonged stress enhances hippocampal glucocorticoid receptor and phosphorylated protein kinase B levels","volume":"75","author":"Eagle","year":"2013","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2025.110675_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2006.06.039","article-title":"Potentiation of cue-induced reinstatement of cocaine-seeking in rats by the anxiogenic drug yohimbine","volume":"174","author":"Feltenstein","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110675_bib17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1521-0391.2013.12074.x","article-title":"Predictive factors for relapse in patients on buprenorphine maintenance","volume":"23","author":"Ferri","year":"2014","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.neuropharm.2025.110675_bib18","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/s41386-019-0390-z","article-title":"Effects of stimulation of mu opioid and nociceptin\/orphanin FQ peptide (NOP) receptors on alcohol drinking in rhesus monkeys","volume":"44","author":"Flynn","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110675_bib19","first-page":"304","article-title":"Influence of the endogenous opioid system on high alcohol consumption and genetic predisposition to alcoholism","volume":"26","author":"Gianoulakis","year":"2001","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110675_bib20","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/alcalc\/agw038","article-title":"Reductions in alcohol craving following naltrexone treatment for heavy drinking","volume":"51","author":"Helstrom","year":"2016","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.neuropharm.2025.110675_bib21","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.biopsych.2015.09.015","article-title":"Capturing individual differences: challenges in animal models of posttraumatic stress disorder and drug abuse","volume":"78","author":"Holly","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110675_bib22","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.bbr.2015.03.043","article-title":"Inhibiting corticosterone synthesis during fear memory formation exacerbates cued fear extinction memory deficits within the single prolonged stress model","volume":"287","author":"Keller","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110675_bib23","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110675_bib24","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1016\/j.bja.2018.10.065","article-title":"BU10038 as a safe opioid analgesic with fewer side-effects after systemic and intrathecal administration in Primates","volume":"122","author":"Kiguchi","year":"2019","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neuropharm.2025.110675_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neuropharm.2025.110675_bib26","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.neubiorev.2004.11.001","article-title":"Anxiety-like behaviors following chronic ethanol exposure","volume":"28","author":"Kliethermes","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2025.110675_bib27","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/sj.npp.1301169","article-title":"The nociceptin\/orphanin FQ receptor agonist Ro 64-6198 reduces alcohol self-administration and prevents relapse-like alcohol drinking","volume":"32","author":"Kuzmin","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110675_bib28","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0306-4530(97)00044-9","article-title":"Stress-restress: effects on ACTH and fast feedback","volume":"22","author":"Liberzon","year":"1997","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2025.110675_bib29","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3389\/fpsyt.2018.00196","article-title":"Single-prolonged stress: a review of two decades of progress in a rodent model of post-traumatic stress disorder","volume":"9","author":"Lisieski","year":"2018","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110675_bib30","doi-asserted-by":"crossref","first-page":"7856","DOI":"10.1523\/JNEUROSCI.22-18-07856.2002","article-title":"Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms","volume":"22","author":"Liu","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110675_bib31","article-title":"Novel pharmacological targets of post-traumatic stress disorders","volume":"13","author":"Marazziti","year":"2023","journal-title":"Life (Basel)"},{"key":"10.1016\/j.neuropharm.2025.110675_bib32","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/acer.14540","article-title":"Housing condition differentially impacts escalation of alcohol intake, relapse-like drinking, anxiety-like behavior, and stress history effects by sex","volume":"45","author":"Moench","year":"2021","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2025.110675_bib33","series-title":"Psychology","author":"Myers","year":"2001"},{"key":"10.1016\/j.neuropharm.2025.110675_bib34","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1021\/cn500342u","article-title":"A rodent model of traumatic stress induces lasting sleep and quantitative electroencephalographic disturbances","volume":"6","author":"Nedelcovych","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110675_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2020.04.003","article-title":"Predicting relapse after alcohol use disorder treatment in a high-risk cohort: the roles of anhedonia and smoking","volume":"126","author":"Nguyen","year":"2020","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2025.110675_bib36","doi-asserted-by":"crossref","first-page":"506","DOI":"10.30773\/pi.2020.0002","article-title":"Protagonist role of opioidergic system on post-traumatic stress disorder and associated pain","volume":"17","author":"Nikbakhtzadeh","year":"2020","journal-title":"Psychia. Investig."},{"key":"10.1016\/j.neuropharm.2025.110675_bib37","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1749-6632.1992.tb25984.x","article-title":"Classical conditioning in drug-dependent humans","volume":"654","author":"O'Brien","year":"1992","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2025.110675_bib38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.physbeh.2014.03.016","article-title":"Moderate treadmill exercise rescues anxiety and depression-like behavior as well as memory impairment in a rat model of posttraumatic stress disorder","volume":"130","author":"Patki","year":"2014","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2025.110675_bib39","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41380-018-0117-2","article-title":"Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches","volume":"24","author":"Pecina","year":"2019","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110675_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2019.100149","article-title":"Sex differences in stress-related alcohol use","volume":"10","author":"Peltier","year":"2019","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.neuropharm.2025.110675_bib41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13293-018-0192-8","article-title":"Sex differences in the traumatic stress response: the role of adult gonadal hormones","volume":"9","author":"Pooley","year":"2018","journal-title":"Biol. Sex Differ."},{"key":"10.1016\/j.neuropharm.2025.110675_bib42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/187152710790966704","article-title":"Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics","volume":"9","author":"Ray","year":"2010","journal-title":"CNS Neurol. Disord.: Drug Targets"},{"key":"10.1016\/j.neuropharm.2025.110675_bib43","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/s41380-018-0272-5","article-title":"Animal models of PTSD: a challenge to be met","volume":"24","author":"Richter-Levin","year":"2019","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110675_bib44","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/mp.2015.169","article-title":"A novel approach to PTSD modeling in rats reveals alternating patterns of limbic activity in different types of stress reaction","volume":"21","author":"Ritov","year":"2016","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110675_bib45","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0306-4603(95)00024-7","article-title":"Understanding comorbidity between PTSD and substance use disorders: two preliminary investigations","volume":"20","author":"Saladin","year":"1995","journal-title":"Addict. Behav."},{"key":"10.1016\/j.neuropharm.2025.110675_bib48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00213-002-1224-x","article-title":"The reinstatement model of drug relapse: history, methodology and major findings","volume":"168","author":"Shaham","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2025.110675_bib49","doi-asserted-by":"crossref","first-page":"414","DOI":"10.35946\/arcr.v34.4.06","article-title":"Anxiety and alcohol use disorders: comorbidity and treatment considerations","volume":"34","author":"Smith","year":"2012","journal-title":"Alcohol Res."},{"key":"10.1016\/j.neuropharm.2025.110675_bib50","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3389\/fphar.2017.00615","article-title":"Using the single prolonged stress model to examine the pathophysiology of PTSD","volume":"8","author":"Souza","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110675_bib51","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/01.ALC.0000158832.07705.22","article-title":"The 8-year course of alcohol abuse: gender differences in social context and coping","volume":"29","author":"Timko","year":"2005","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2025.110675_bib52","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bbr.2014.06.039","article-title":"Only susceptible rats exposed to a model of PTSD exhibit reactivity to trauma-related cues and other symptoms: an effect abolished by a single amphetamine injection","volume":"272","author":"Toledano","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110675_bib53","series-title":"PTSD","article-title":"U.S. department of veterans affairs","year":"2022"},{"key":"10.1016\/j.neuropharm.2025.110675_bib54","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00221-014-3890-4","article-title":"Trauma exposure and sleep: using a rodent model to understand sleep function in PTSD","volume":"232","author":"Vanderheyden","year":"2014","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110675_bib55","doi-asserted-by":"crossref","first-page":"193","DOI":"10.35946\/arcr.v39.2.09","article-title":"Pharmacotherapy for Co-Occurring alcohol use disorder and post-traumatic stress disorder: targeting the opioidergic, noradrenergic, serotonergic, and GABAergic\/Glutamatergic systems","volume":"39","author":"Verplaetse","year":"2018","journal-title":"Alcohol Res."},{"key":"10.1016\/j.neuropharm.2025.110675_bib56","series-title":"2024 MHSRS: Military Health System Research Symposium","article-title":"PPL-138, a mixed NOP\/opioid receptor modulator, reduces pain sensitivity and anxiety-like behavior in a preclinical model of post-traumatic stress disorder (PTSD)","author":"Zhang","year":"2024"},{"key":"10.1016\/j.neuropharm.2025.110675_bib57","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1744-8069-8-76","article-title":"Increased nociceptive sensitivity and nociceptin\/orphanin FQ levels in a rat model of PTSD","volume":"8","author":"Zhang","year":"2012","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2025.110675_bib58","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/bph.12701","article-title":"Nociceptin\/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder","volume":"172","author":"Zhang","year":"2015","journal-title":"Br. J. Pharmacol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825003831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825003831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T20:42:48Z","timestamp":1772829768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825003831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":56,"alternative-id":["S0028390825003831"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110675","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Testing the effect of the non-selective opioid PPL-138 in a model of alcohol relapse in the context of PTSD","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110675","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110675"}}